5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Patent Ductus Arteriosus
Patent Ductus Arteriosus (PDA) is a congenital heart defect that occurs when the ductus arteriosus, a blood vessel connecting the pulmonary artery to the aorta in fetal circulation, fails to close after birth. In a normal heart, the ductus arteriosus closes shortly after a baby is born, redirecting blood flow. However, in cases of PDA, the opening persists, allowing oxygenated and deoxygenated blood to mix, putting strain on the heart and potentially causing complications. Symptoms may include difficulty breathing, poor weight gain, and an increased risk of respiratory infections. Timely diagnosis and intervention, often through medication or surgical closure, are crucial in managing PDA and preventing long-term complications in affected individuals.
John R Doty
Intermountain Medical Center, United States
Agustin Joison
Cordoba Catholic University, Argentina
Thomas J Webster
Brown University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sergey Suchkov
N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Bijoy Krishna Banik
National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, IndiaSubmit your abstract Today
Title : Healing a broken heart: One nano beat at a time
Thomas J Webster, Brown University, United States
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Antidiabetic agents – From treating diabetes to providing positive cardiovascular outcome
Syed Raza, Awali Hospital, Bahrain